Every month PharmaShots explores a new theme to add character and depth to our magazine. March 2024 edition is exploring Precision medicine as a theme. Imbued with curated themes delving deep into assorted segments designed to keep you hooked throughout the magazine. PharmaShots magazine also provides a glimpse of our monthly activities to keep you up-to-date on the developments of the biopharmaceutical industry.

With incessant innovation significantly influencing the way we receive healthcare services; Precision Medicine is gradually pacing ahead to make a prominent position in diagnostics and therapeutics. The magazine navigates the intricacies of precision medicine and takes you on an engaging excursion to learning, innovation, and trends.

This month the center of attention remained the Spotlight Interview with David Esposito from ONL Therapeutics and David A. Dodd from GeoVax Labs.

Our most-viewed Top 20 reports on Top 20 Life Sciences Deals of 2023 by Total Deal Value and Top 20 Radiopharma Companies Based on Market Cap registered overwhelming responses. On the top-performing drug Edition, we covered Entyvio, and the Disease of the Month report was focused on Neuroblastoma.

In the Know Your Investor report, we prepared a condensed analysis of F-Prime Capital Partners. As promised to our viewers, we published A Complete Account of FDA Approvals in 2023. Like every month, we published reports on the US FDA approvals, EMA approvals, biosimilars, & new drug designations to keep our audiences up to date on biopharma developments. In association with Ingenious E-Brain, PharmaShots as a media partner covered a two-day virtual event Oncovision focused on oncology.

Want to advertise in PharmaShots Magazine for FREE? Email us at connect@pharmashots.com